TrialBMC nephrology2015

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial.

Akio Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.